CORONA Remedies: 22nd AGM on July 9, 2026; ₹10 dividend proposed.
CORONA Remedies Limited will hold its 22nd AGM on July 9, 2026. The Board has recommended a dividend of ₹10 per equity share for FY 2025-26, subject to member approval at the AGM. Shareholders need to update KYC details for electronic dividend payment.
The declaration of a dividend and the scheduling of an AGM are significant events for shareholders, impacting their investment and participation in company governance.
The announcement details a proposed dividend and the upcoming AGM, which are positive financial and governance events for shareholders.
CORONA Remedies Limited has announced the details for its 22nd Annual General Meeting (AGM), scheduled to be held on Thursday, July 09, 2026, at 11:00 AM IST. The meeting will be conducted through Video Conferencing / Other Audio Visual Means.
Additionally, the Board of Directors, in a meeting held on May 11, 2026, recommended a dividend of ₹10 per equity share of ₹10 each for the financial year ended March 31, 2026. This dividend is subject to the approval of the members at the upcoming AGM. Shareholders are advised that dividends will be paid electronically, and they are requested to update their KYC details, including PAN, nomination choice, email IDs, mobile number, and bank account information, with their respective Depository Participants (DP).
The company is also providing access to the Notice of the 22nd AGM and the Annual Report for FY 2025-26. Members who have not registered their email IDs will receive a letter with a weblink and the path to access these documents on the company's website: www.coronaremedies.com.
What to do with a filing like this
CORONA Remedies Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by CORONA Remedies Limited. Read the original for the full detail.